Cybin Corp.

NEO: CYBN

Company Logo

Company Overview

Cybin Corp. is focused on furthering the research and development of psilocybin through its wholly-owned subsidiary, Serenity Life Sciences Inc., and developing proprietary medicinal mushroom products through its wholly-owned subsidiary, Natures Journey Inc. 

The company's IP strategy revolves around psychedelic delivery mechanisms, synthetic compounds, extraction methods, isolation of chemical compounds, new drug formulations, and protocol regiments. Its experienced management team has run multiple clinical trials and successfully brought many new drugs to market in the past.

Financial Highlights

$0

Revenue (ttm)

$0

Gross Profit (ttm)

-$0.26

Diluted EPS (ttm)

Management Team

Mr. Eric So L.L.B., LLB
Co-Founder, Pres & Exec. Chairman

Mr. Douglas L. Drysdale
Chief Exec. Officer

Mr. Paul Glavine
Co-Founder, COO & Director

Mr. John Kanakis
Co-Founder & Sr. VP of Bus. Devel.

Mr. Greg Cavers
Chief Financial Officer

Dr. Alex L. Nivorozhkin Ph.D.
Chief Scientific Officer

Lori Challenger
Chief of Staff

Mr. Gabriel Fahel
Chief Legal Officer

Sara Brittany Somerset
Chief Communications Officers

James Andrews
Chief Cultivation & Extraction Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization

Shares Outstanding
0

Shares Short (% of Float)
0 (0%)

Insider Ownership
0%